RS50289B - Novi razgranati supstituisani amino derivati od 3-amino-1- fenil-1h(1,2,4) triazola, postupak za njihovo dobijanje i farmaceutski preparati koji ih sadrže - Google Patents

Novi razgranati supstituisani amino derivati od 3-amino-1- fenil-1h(1,2,4) triazola, postupak za njihovo dobijanje i farmaceutski preparati koji ih sadrže

Info

Publication number
RS50289B
RS50289B YUP-439/02A YUP43902A RS50289B RS 50289 B RS50289 B RS 50289B YU P43902 A YUP43902 A YU P43902A RS 50289 B RS50289 B RS 50289B
Authority
RS
Serbia
Prior art keywords
alkyl
cyclopropyl
triazol
amine hydrochloride
propyl
Prior art date
Application number
YUP-439/02A
Other languages
English (en)
Serbian (sr)
Inventor
Michel Geslin
Jean-Pierre Maffrand
Danielle Gully
Pierre Roger
Original Assignee
Sanofi-Aventis,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis, filed Critical Sanofi-Aventis,
Publication of YU43902A publication Critical patent/YU43902A/sh
Publication of RS50289B publication Critical patent/RS50289B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
YUP-439/02A 1999-12-17 2000-12-14 Novi razgranati supstituisani amino derivati od 3-amino-1- fenil-1h(1,2,4) triazola, postupak za njihovo dobijanje i farmaceutski preparati koji ih sadrže RS50289B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9915935A FR2802530B1 (fr) 1999-12-17 1999-12-17 Nouveaux derives amino substitues ramifies du 3-amino-1-phenyl-1h[1,2,4]triazole, procedes pour leur preparation et compositions pharmaceutiques les contenant

Publications (2)

Publication Number Publication Date
YU43902A YU43902A (sh) 2005-03-15
RS50289B true RS50289B (sr) 2009-09-08

Family

ID=9553380

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-439/02A RS50289B (sr) 1999-12-17 2000-12-14 Novi razgranati supstituisani amino derivati od 3-amino-1- fenil-1h(1,2,4) triazola, postupak za njihovo dobijanje i farmaceutski preparati koji ih sadrže

Country Status (33)

Country Link
US (1) US6806282B2 (enExample)
EP (1) EP1242389B1 (enExample)
JP (1) JP4146641B2 (enExample)
KR (1) KR100705525B1 (enExample)
CN (1) CN1293061C (enExample)
AR (1) AR031837A1 (enExample)
AT (1) ATE264847T1 (enExample)
AU (1) AU780711B2 (enExample)
BR (1) BR0017023A (enExample)
CA (1) CA2398772C (enExample)
CO (1) CO5251379A1 (enExample)
CZ (1) CZ302460B6 (enExample)
DE (1) DE60010126T2 (enExample)
DK (1) DK1242389T3 (enExample)
EA (1) EA004957B1 (enExample)
EE (1) EE04778B1 (enExample)
ES (1) ES2219436T3 (enExample)
FR (1) FR2802530B1 (enExample)
HU (1) HUP0204080A3 (enExample)
IL (2) IL150037A0 (enExample)
IS (1) IS2315B (enExample)
ME (1) MEP12108A (enExample)
MX (1) MXPA02006033A (enExample)
NO (1) NO20022828L (enExample)
PL (1) PL203819B1 (enExample)
PT (1) PT1242389E (enExample)
RS (1) RS50289B (enExample)
SK (1) SK285994B6 (enExample)
TR (2) TR200401775T4 (enExample)
TW (1) TWI289554B (enExample)
UA (1) UA73333C2 (enExample)
WO (1) WO2001044207A2 (enExample)
ZA (1) ZA200204422B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7226920B2 (en) * 2003-08-06 2007-06-05 Vertex Pharmaceuticals Inc. Aminotriazole compounds useful as inhibitors of protein kinases
JO3019B1 (ar) 2006-04-19 2016-09-05 Janssen Pharmaceutica Nv ثلاثي مستبدل 4،2،1-ثلاثي زولات
ES2424023T3 (es) 2007-10-18 2013-09-26 Janssen Pharmaceutica N.V. 1,2,4-triazoles trisustituidos
JO2784B1 (en) 2007-10-18 2014-03-15 شركة جانسين فارماسوتيكا ان. في 5,3,1 - Triazole substitute derivative
MY152486A (en) * 2008-03-19 2014-10-15 Janssen Pharmaceutica Nv Trisubstituted 1,2,4 - triazoles as nicotinic acetylcholine receptor modulators
US8779158B2 (en) 2008-05-09 2014-07-15 Janssen Pharmaceutica Nv Trisubstituted pyrazoles as acetylcholine receptor modulators
EP2629616A4 (en) * 2010-10-21 2014-03-26 Merck Sharp & Dohme SUBSTITUTED AMINO-TRIAZOLYL-PDE10-HEMMER
LT3096756T (lt) 2014-01-21 2024-08-26 Neurocrine Biosciences, Inc. Crf1 receptoriaus antagonistai, skirti įgimtos antinksčių hiperplazijos gydymui
CN104059027B (zh) * 2014-07-01 2015-10-28 河北大学 一类含1,2,4-三唑的(e)-甲氧基亚氨基苯乙酸甲酯类化合物及其制备方法和用途
FI3984523T3 (fi) 2018-12-07 2025-10-21 Neurocrine Biosciences Inc Crf1-reseptorin antagonisti, lääkeformulaatioita ja niiden kiinteitä muotoja synnynnäisen lisämunuaisten liikakasvun hoitoon
KR20220069008A (ko) * 2019-09-25 2022-05-26 온코아렌디 테라퓨틱스 에스.에이. 5-(4-((2s,5s)-5-(4-클로로벤질)-2-메틸모르폴리노)피페리딘-1-일)-1h-1,2,4-트리아졸-3-아민의 생성 방법
CA3152590A1 (en) 2019-09-27 2021-04-01 Evan Smith Crf receptor antagonists and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3869167D1 (de) * 1987-03-27 1992-04-23 Kumiai Chemical Industry Co Phenyltriazol-derivate und insectizid.
US5795905A (en) * 1995-06-06 1998-08-18 Neurocrine Biosciences, Inc. CRF receptor antagonists and methods relating thereto
FR2763337B1 (fr) * 1997-05-13 1999-08-20 Sanofi Sa Nouveaux derives du triazole, un procede pour leur preparation et compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
EP1242389A2 (fr) 2002-09-25
AU2525901A (en) 2001-06-25
ATE264847T1 (de) 2004-05-15
EA200200523A1 (ru) 2002-12-26
WO2001044207B1 (fr) 2002-06-06
PL203819B1 (pl) 2009-11-30
AR031837A1 (es) 2003-10-08
SK285994B6 (sk) 2008-01-07
EE04778B1 (et) 2007-02-15
CZ20022099A3 (cs) 2002-09-11
IL150037A (en) 2007-02-11
FR2802530B1 (fr) 2002-02-22
PT1242389E (pt) 2004-08-31
DE60010126D1 (de) 2004-05-27
CZ302460B6 (cs) 2011-06-01
UA73333C2 (en) 2005-07-15
EP1242389B1 (fr) 2004-04-21
CA2398772A1 (fr) 2001-06-21
HUP0204080A2 (hu) 2003-04-28
TR200401775T4 (tr) 2004-09-21
IS2315B (is) 2007-11-15
PL355811A1 (en) 2004-05-17
CO5251379A1 (es) 2003-02-28
SK8502002A3 (en) 2003-02-04
KR20020061002A (ko) 2002-07-19
ES2219436T3 (es) 2004-12-01
NO20022828D0 (no) 2002-06-13
WO2001044207A3 (fr) 2001-12-20
TWI289554B (en) 2007-11-11
CN1293061C (zh) 2007-01-03
IS6402A (is) 2002-05-28
IL150037A0 (en) 2002-12-01
BR0017023A (pt) 2002-12-03
MEP12108A (en) 2010-06-10
AU780711B2 (en) 2005-04-14
EA004957B1 (ru) 2004-10-28
TR200201600T2 (tr) 2002-10-21
DE60010126T2 (de) 2005-04-28
CN1434808A (zh) 2003-08-06
WO2001044207A2 (fr) 2001-06-21
US20030162771A1 (en) 2003-08-28
DK1242389T3 (da) 2004-08-09
ZA200204422B (en) 2003-11-26
YU43902A (sh) 2005-03-15
JP4146641B2 (ja) 2008-09-10
CA2398772C (fr) 2011-07-05
MXPA02006033A (es) 2003-01-28
US6806282B2 (en) 2004-10-19
FR2802530A1 (fr) 2001-06-22
JP2003516975A (ja) 2003-05-20
WO2001044207A8 (fr) 2001-07-12
EE200200331A (et) 2003-06-16
NO20022828L (no) 2002-08-19
KR100705525B1 (ko) 2007-04-10
HUP0204080A3 (en) 2005-01-28
HK1055947A1 (en) 2004-01-30

Similar Documents

Publication Publication Date Title
RU2146253C1 (ru) Производные 4-фениламинотиазола, способы их получения и фармацевтическая композиция
JPH04506222A (ja) Ｎ−置換複素環誘導体およびその製法
US20070281919A1 (en) Aminothiazole Derivatives And Their Use As CRF Receptor Ligands
RS50289B (sr) Novi razgranati supstituisani amino derivati od 3-amino-1- fenil-1h(1,2,4) triazola, postupak za njihovo dobijanje i farmaceutski preparati koji ih sadrže
SK5712003A3 (en) Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same
EP4519250A1 (en) Pyridone compounds as trpa1 inhibitors
JP2008523155A (ja) ピリジル置換スピロ−ヒダントイン化合物およびその使用
CA2007401A1 (fr) Derives des bisarylalcenes, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
CA2573066A1 (en) Mercaptoimidazoles as ccr2 receptor antagonists
WO2025014922A1 (en) Bicyclic and monocyclic trpa1 inhibitors
MXPA97010378A (en) Derivatives of 4-finilaminotiazol, its process of preparation and the pharmaceutical compositions that contains them